Massachusetts Weekly
SEE OTHER BRANDS

The most trusted news from Massachusetts

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on July 7, 2025

Access Fixtures Launches TEME Lantern Style LED Post Top Light

Access Fixtures Launches TEME Lantern Style LED Post Top Light

Access Fixtures launches the new TEME LED Post Top Light. With a classic design and modern tech, it's spec-grade, BABA compliant, and EXTREME-LIFE rated. WORCESTER, MA, UNITED STATES, July 7, 2025 /⁨EINPresswire.com⁩/ -- Access Fixtures, a leader in …

Cape Cod’s Trusted Buyer Makes Selling Silver and Gold Simple, Safe, and Profitable

Cape Cod’s Trusted Buyer Makes Selling Silver and Gold Simple, Safe, and Profitable

As more residents across Cape Cod, MA look to unlock the value in their precious metals, Eagle Coins continues to be the area’s most trusted destination CAPE COD, MA, UNITED STATES, July 7, 2025 /⁨EINPresswire.com⁩/ -- As more residents across Harwich, …

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

APEX Part A met all primary and key secondary endpoints and exceeded trial objectives, including 71.0% decrease from baseline in EASI at Week 16 APG777 demonstrated EASI-75 of 66.9% (42.5% placebo-adjusted) at Week 16, the highest topline and placebo- …

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

Boston, MA and Providence, RI, July 07, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service